SI0946150T1 - Oral preparation containing at least one active pharmaceutical substance in a matrix capable of swelling in an aqueous medium - Google Patents

Oral preparation containing at least one active pharmaceutical substance in a matrix capable of swelling in an aqueous medium

Info

Publication number
SI0946150T1
SI0946150T1 SI9730331T SI9730331T SI0946150T1 SI 0946150 T1 SI0946150 T1 SI 0946150T1 SI 9730331 T SI9730331 T SI 9730331T SI 9730331 T SI9730331 T SI 9730331T SI 0946150 T1 SI0946150 T1 SI 0946150T1
Authority
SI
Slovenia
Prior art keywords
swelling
aqueous medium
active pharmaceutical
preparation containing
oral preparation
Prior art date
Application number
SI9730331T
Other languages
English (en)
Slovenian (sl)
Inventor
Karsten Cremer
Original Assignee
Lts Lohmann Therapie-Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie-Systeme Ag filed Critical Lts Lohmann Therapie-Systeme Ag
Publication of SI0946150T1 publication Critical patent/SI0946150T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SI9730331T 1996-09-28 1997-08-29 Oral preparation containing at least one active pharmaceutical substance in a matrix capable of swelling in an aqueous medium SI0946150T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19640062A DE19640062B4 (de) 1996-09-28 1996-09-28 Orale Zubereitung, enthaltend in einer in wässrigem Medium quellbaren Matrix wenigstens einen pharmazeutischen Wirkstoff
EP97944810A EP0946150B1 (de) 1996-09-28 1997-08-29 Orale zubereitung, enthaltend in einer in wässrigem medium quellbaren matrix wenigstens einen pharmazeutischen wirkstoff
PCT/EP1997/004717 WO1998013028A1 (de) 1996-09-28 1997-08-29 Orale zubereitung, enthaltend in einer in wässrigem medium quellbaren matrix wenigstens einen pharmazeutischen wirkstoff

Publications (1)

Publication Number Publication Date
SI0946150T1 true SI0946150T1 (en) 2002-08-31

Family

ID=7807265

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9730331T SI0946150T1 (en) 1996-09-28 1997-08-29 Oral preparation containing at least one active pharmaceutical substance in a matrix capable of swelling in an aqueous medium

Country Status (23)

Country Link
US (1) US6238698B1 (xx)
EP (1) EP0946150B1 (xx)
JP (1) JP2001504807A (xx)
KR (1) KR100493139B1 (xx)
CN (1) CN1139378C (xx)
AT (1) ATE213933T1 (xx)
AU (1) AU724802B2 (xx)
CA (1) CA2260845C (xx)
CZ (1) CZ291258B6 (xx)
DE (2) DE19640062B4 (xx)
DK (1) DK0946150T3 (xx)
ES (1) ES2174296T3 (xx)
HU (1) HU227865B1 (xx)
IL (1) IL129171A (xx)
MY (1) MY130959A (xx)
NO (1) NO991477D0 (xx)
NZ (1) NZ333401A (xx)
PL (1) PL188392B1 (xx)
PT (1) PT946150E (xx)
SI (1) SI0946150T1 (xx)
SK (1) SK282709B6 (xx)
WO (1) WO1998013028A1 (xx)
ZA (1) ZA978625B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR030557A1 (es) * 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US8487002B2 (en) 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
TWI319713B (en) 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
CA2491665A1 (fr) * 2004-12-24 2006-06-24 Louis Cartilier Formulation de comprime pour liberation soutenue de principe actif
JP5269595B2 (ja) * 2005-09-09 2013-08-21 アンジェリーニ ラボファーム リミテッド ライアビリティ カンパニー １日１回投与用トラゾドン組成物
US20080286343A1 (en) * 2007-05-16 2008-11-20 Dzenana Cengic Solid form
CA2750421C (en) 2008-11-27 2016-10-18 B.R.A.I.N. Biotechnology Research And Information Network Ag Surface active proteins as excipients in solid pharmaceutical formulations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1237904B (it) 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
CA2041774C (en) * 1990-11-27 1994-04-19 Mircea A. Mateescu Use of cross-linked amylose as a matrix for the slow release of biologically active compounds
US5603956A (en) * 1990-11-27 1997-02-18 Labopharm Inc. Cross-linked enzymatically controlled drug release
KR100304997B1 (ko) 1992-07-24 2002-04-24 드니랑글로아 효소에의해제어되는약물방출을위한가교결합된폴리하이드록실물질을포함하는정제
US5616343A (en) * 1993-03-25 1997-04-01 Labopharm, Inc. Cross-linked amylose as a binder/disintegrant in tablets
DE4341442C2 (de) 1993-12-04 1998-11-05 Lohmann Therapie Syst Lts Vorrichtung zur kontrollierten Freisetzung von Wirkstoffen sowie ihre Verwendung
DE4416926C2 (de) 1994-05-13 2000-01-13 Lohmann Therapie Syst Lts Verfahren zur Herstellung von Vorrichtungen zur kontrollierten Freisetzung von Wirkstoffen
IT1282650B1 (it) * 1996-02-19 1998-03-31 Jagotec Ag Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
EP1984443B1 (en) 2006-02-14 2014-04-02 The Procter and Gamble Company Personal care compositions comprising responsive particles

Also Published As

Publication number Publication date
PT946150E (pt) 2002-08-30
ZA978625B (en) 1998-03-26
EP0946150B1 (de) 2002-03-06
CN1231600A (zh) 1999-10-13
CA2260845C (en) 2005-11-22
HUP9903115A2 (hu) 2000-02-28
ATE213933T1 (de) 2002-03-15
HUP9903115A3 (en) 2000-03-28
CZ101399A3 (cs) 1999-07-14
CA2260845A1 (en) 1998-04-02
DE59706576D1 (de) 2002-04-11
KR100493139B1 (ko) 2005-06-02
ES2174296T3 (es) 2002-11-01
EP0946150A1 (de) 1999-10-06
NO991477L (no) 1999-03-26
AU724802B2 (en) 2000-09-28
JP2001504807A (ja) 2001-04-10
NZ333401A (en) 1999-10-28
AU4619397A (en) 1998-04-17
MY130959A (en) 2007-07-31
PL332577A1 (en) 1999-09-27
WO1998013028A1 (de) 1998-04-02
NO991477D0 (no) 1999-03-26
SK38799A3 (en) 2000-03-13
IL129171A (en) 2001-11-25
KR20010029533A (ko) 2001-04-06
US6238698B1 (en) 2001-05-29
HU227865B1 (en) 2012-05-29
IL129171A0 (en) 2000-02-17
DK0946150T3 (da) 2002-06-24
CZ291258B6 (cs) 2003-01-15
PL188392B1 (pl) 2005-01-31
SK282709B6 (sk) 2002-11-06
DE19640062B4 (de) 2006-04-27
CN1139378C (zh) 2004-02-25
DE19640062A1 (de) 1998-04-09

Similar Documents

Publication Publication Date Title
ATE269709T1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
AU610112B2 (en) Tablet for pharmaceutical use able to release active substances at successive times
BR9708772A (pt) "comprimidos famacêuticos de liberação controlada que contém um veìculo à base de amilose reticulada e hidróxi propil metil celulose"
AU3912089A (en) Multilayer plaster
ITMI922617A1 (it) Forme matriciali multistrato per il rilascio controllato di principi attivi
FI944035A (fi) Tramadolisuolaa sisältävä lääkeaine, jolla on viivästynyt vaikuttavan aineen vapautuminen
ZA977832B (en) Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents.
AU1023788A (en) Therapeutic system for sparingly soluble active ingredients
AU3268689A (en) Transdermal monolith systems
ES2182397T3 (es) Comprimido para la liberacion instantanea y prolongada de una o mas substancias activas.
ATE68969T1 (de) Im magen verbleibende granula.
NZ298994A (en) Drug dosage form containing a core having at least two layers, both containing a polymer that forms microscopic gel beads upon hydration but only one contains the drug and an impermeable, insoluble coating containing apertures which provide for the hydration and release of the beads
IL129171A0 (en) Oral preparation containing at least one active pharmaceutical substance in a matrix capable of swelling in an aqueous medium
MY111126A (en) Transdermal therapeutic system comprising the active substance acetylsalicylic acid.
WO1998038983A3 (en) Swallow tablet comprising paracetamol
NO970610L (no) Sammensetning for selektiv frigjöring av en aktiv ingrediens
DK0615442T3 (da) Solreguleret termokolloidmatrix på gelatinebasis til perorale former med retarderet frigivelse.
EP0070127A3 (en) Tablets
WO1994025025A3 (de) Systeme zur kontrollierten abgabe von pilocarpin
ES2176702T3 (es) Antimicoticos con alta liberacion de sustancia activa.
ES8603262A1 (es) Perfeccionamientos en formas farmaceuticas solidas para uso oral
DE3772954D1 (de) Arzneimittel mit verzoegerter wirkstoffabgabe.
HUP9902681A2 (hu) Térhálósított amilózt és hidroxi-propil-metil-cellulózt tartalmazó hordozóval készült szabályozott felszabadulású tabletta gyógyszerkészítmény
IT1275267B (it) Forme farmaceutiche a rilascio modificato di canrenoato di potassio costituite da matrici idrofile rivestite
AU4015097A (en) Transdermal therapeutic system having an active compound combination comprising oestriol